Zhitong Finance App News, Jin Dawei (002626.SZ) issued an announcement. Recently, Inner Mongolia Jindaway Pharmaceutical Co., Ltd. (hereinafter referred to as “Jindaway Pharmaceutical”), a wholly-owned subsidiary of the company, received a letter of no objection from GRAS Notice No. GRN 001305 issued by the US Food and Drug Administration (FDA). Jindaway Pharmaceuticals' Brazilian sweet protein (Brazzein preparation) product has completed the FDA GRAS notification evaluation, and the FDA has issued no objections to the GRAS (GRAS) conclusion under the declared use of this product.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.